3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
2
Multiple Myeloma
2
Respiratory Distress Syndrome
1
Pulmonary Embolism
1
Pneumonia, Viral
1
Motor Activity
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Cytokine Release Syndrome
1
Interventions
apixaban
2
Rivaroxaban
2
Enoxaparin
2
enoxaparin sodium
1
edoxaban
1
Warfarin
1
Tinzaparin
1
Hospitals
1
Heparin, Low-Molecular-Weight
1
Fondaparinux
1
Educational Status
1
Dalteparin
1
Dabigatran
1
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pulmonary Embolism
×
Heparin, Low-Molecular-Weight
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled